Cancer Supportive Care Drugs Market Analysis By 2026

Cancer supportive care is associated with care given to the patients suffering from various types of cancer. Supportive care is intended for relieving suffering of the patients and improving their quality of life. These treatments are not intended to cure the disease itself, however, to treat the side effects and symptoms such as pain and stress.

Request for Sample Copy of Research Report@
https://www.coherentmarketinsights.com/insight/request-sample/2013

Government organizations and institutions are focusing on promoting better palliative/supportive care to improve patients’ quality of life. For instance, the American Cancer Society has collaborated with various institutions such as National Palliative Care Research Center (NPCRC) (in 2007) to improve cancer supportive care and to promote palliative care. Moreover, the American Cancer Society Cancer Action Network (ACS CAN) is working to improve access to palliative care services for adults and children that are severely suffering from various types of cancer.

Cancer Supportive Care Drugs Market Drivers

High prevalence of various types of cancer is a key factor supporting growth of the global cancer supportive care drugs market. Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its invasive nature and prolonged duration of disease. According to National Cancer Institute, around 1,735,350 new cancer cases are expected to be diagnosed in the U.S. in 2018. The most common cancers are lung cancer, breast cancer, prostate cancer, melanoma, bladder cancer, and others.

Cancer treatment includes chemotherapy, radiation therapy, targeted therapy, hormone replacement therapy, and others. These therapies have their own advantages and side effects. Cancer supportive care drugs are primarily used to aid in treatment of side effects associated with various cancer treatments. Increasing demand for various cancer therapies, owing to high prevalence of the disease is expected to boost the global cancer supportive care drugs market growth over the forecast period. According to American Cancer Society, in 2017, around 222,500 new cases of lung cancer were registered and around 155,870 deaths recorded due to lung cancer in the U.S.

Cancer Supportive Care Drugs Market Regional Insights

North America and Europe are expected to witness significant growth in the cancer supportive care drugs market over the forecast period. New product launches of cancer supportive care drugs and increasing demand for such drugs, owing to high prevalence of the disease is expected to facilitate growth of the cancer supportive care drugs market, in the U.S. For instance, according to the American Cancer Society, in 2017, around 225,000 cases of lung cancer were registered in the U.S. Furthermore, presence of leading manufacturers such as Amgen, Inc.

Cancer Supportive Care Drugs Market Key Player

Key players operating in the cancer supportive care drugs market include Johnson & Johnson, Novartis AG, F.Hoffmann La-Roche Ltd., Amgen, Inc., Baxter International, Inc., Teva Pharmaceutical Industries Ltd., Acacia Pharma Ltd., Merck & Co., Inc., Helsinn Healthcare SA, and Heron Therapeutics.

Request for Discount Before Buying This Business Reports @ https://www.coherentmarketinsights.com/insight/request-discount/2013

Cancer Supportive Care Drugs Market Taxonomy

The global cancer supportive care drugs market is segmented on the basis of drug type, cancer type, distribution channel, and region.

By Drug Type -

Antiemetic

Bisphosphonates

Opioids

NSAIDs

G-Colony Stimulating Factors

Erythropoietin Stimulating Agents

Others

By Cancer Type -

Lung Cancer

Breast Cancer

Prostate Cancer

Liver Cancer

Melanoma

Bladder Cancer

Leukemia

Ovarian Cancer

Others

By Distribution Channel -

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region -

North America

Europe

Asia Pacific

Latin America

Middle East

Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1–206–701–6702

Email:- sales@coherentmarketinsights.com

This release was published on openPR.